Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-MUST in Chronic Cholecystitis and Biliary Tract Dyskinesia
NCT07595003Phase 3Recruiting
- Sponsor
- Valenta Pharm
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 4-MUST in chronic cholecystitis, biliary dyskinesia, sponsored by Valenta Pharm. Started Dec 2025; status: recruiting.
02
Drugs
4-MUST
03
Conditions
chronic cholecystitisbiliary dyskinesia
Beyond the preview
Go deeper on NCT07595003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07595003.